Vitamin D: Large Trials, Small Effects
Observational data promised a great deal. The randomised trials that followed found much less.
Dr. Elena Vance
Chief of Research
Sep 16, 2026 • 10 min
What the data says
~25,000
Participants in the largest randomised vitamin D trial, which found no reduction in its primary endpoints.
Source: Large randomised supplementation trials
Low vitamin D correlates with almost every poor health outcome measured, which was always suspicious: illness reduces outdoor activity, and adiposity sequesters the vitamin in fat tissue.
The large randomised trials tested supplementation against placebo in mostly replete populations and found no effect on their primary cardiovascular or cancer endpoints. Subgroup signals exist but are the kind that need their own trial.
Where supplementation clearly matters is deficiency, which is common at high latitudes in winter, in people with darker skin at those latitudes, and in those who cover up or stay indoors.
Testing before supplementing is more informative than dosing blind, and high-dose intermittent regimens have performed worse than modest daily ones in fracture trials.
Editorial note: this article summarises published research for general information. It is not medical advice. Discuss any intervention with a qualified clinician.
